Mounjaro is approved for diabetes, while Zepbound is approved for weight loss
Trouble wearing contact lenses or driving at night
They offer convenience, flexibility and can easily be incorporated into an existing wellness routine
In trials involving 176 participants across four randomized controlled studies, liraglutide was used in 58% of cases (103 participants), while semaglutide was used in 13% (23 participants)
Breaking down GLP-1 drugs and disease management Drugs like Ozempic, Rybelsus, Wegovy, Zepbound and Mounjaro are out in the market and surging in popularity
Multimodal weight loss compounds that integrate agonism at two or more receptor systems are emerging 27,43,44,45